Literature DB >> 3143445

Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.

J Main1, H McKenzie, G R Yeaman, M A Kerr, D Robson, C R Pennington, D Parratt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3143445      PMCID： PMC1834894          DOI： 10.1136/bmj.297.6656.1105

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease.

Authors:  R Paganelli; F Pallone; S Montano; S Le Moli; P M Matricardi; S Fais; P Paoluzi; R D'Amelio; F Aiuti
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

2.  Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease.

Authors:  P Knoflach; B H Park; R Cunningham; M M Weiser; B Albini
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

3.  Diagnosis of inflammatory bowel disease: an international multicentre scoring system.

Authors:  S E Clamp; J Myren; I A Bouchier; G Watkinson; F T de Dombal
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

4.  Saccharomyces cerevisiae infections in man.

Authors:  R H Eng; R Drehmel; S M Smith; E J Goldstein
Journal:  Sabouraudia       Date:  1984
  4 in total
  82 in total

Review 1.  Diagnostic methodologies: serology, endoscopy, and radiology.

Authors:  T Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2001-12

2.  Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.

Authors:  Zhaoxia Zhang; Chen Li; Xinmei Zhao; Chaolan Lv; Qiong He; Shan Lei; Yandong Guo; Fachao Zhi
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

3.  Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.

Authors:  M H Giaffer; A Clark; C D Holdsworth
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

4.  Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.

Authors:  I E A Hoffman; P Demetter; M Peeters; M De Vos; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

5.  Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis.

Authors:  Albert J Czaja; Zakera Shums; Peter T Donaldson; Gary L Norman
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

6.  Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.

Authors:  L G Wayne; D Hollander; B Anderson; H A Sramek; C M Vadheim; J I Rotter
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

7.  Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.

Authors:  Hiromasa Takaishi; Takanori Kanai; Atsushi Nakazawa; Fumihiko Sugata; Akira Nikai; Shigeo Yoshizawa; Yasuo Hamamoto; Shinsuke Funakoshi; Tomoharu Yajima; Yasushi Iwao; Masao Takemura; Shoichi Ozaki; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-05-30       Impact factor: 7.527

Review 8.  The status of diagnostic markers for inflammatory bowel disease.

Authors:  Poonam Beniwal; Laura Harrell
Journal:  Curr Gastroenterol Rep       Date:  2010-12

9.  Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.

Authors:  J Halfvarson; A Standaert-Vitse; G Järnerot; B Sendid; T Jouault; L Bodin; A Duhamel; J F Colombel; C Tysk; D Poulain
Journal:  Gut       Date:  2005-04-29       Impact factor: 23.059

10.  Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.

Authors:  Simone Saibeni; Maria J Etchevers; Dolors Tassies; Julián Panés; Joan C Reverter; Silvio Danese; Josep M Piqué; Savino Bruno; Maurizio Vecchi; Antonio Gasbarrini; Miquel Sans
Journal:  Int J Colorectal Dis       Date:  2013-04-16       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.